Nrx pharmaceuticals to report fourth quarter and full year 2022 financial results on march 30, 2023

Radnor, pa. , march 17, 2023 /prnewswire/ -- nrx pharmaceuticals, inc. (nasdaq: nrxp) ("nrx pharmaceuticals", the "company"), a clinical-stage cns biopharmaceutical company, a delaware corporation, today announced that it will release its fourth quarter and full year 2022 financial results after the market closes on thursday, march 30, 2023, via press release, which will be available on the company's website at https://ir.nrxpharma.com/.
NRXP Ratings Summary
NRXP Quant Ranking